Post-marketing safety surveillance of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine: a disproportionality analysis of the vaccine adverse event reporting system (2015-2025).

Song W, Chen H, Wang M, Liang Z

Open source

DOI
10.3389/fcimb.2026.1831548
Published
2026
Container
Frontiers in cellular and infection microbiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcimb.2026.1831548,
  title = {Post-marketing safety surveillance of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine: a disproportionality analysis of the vaccine adverse event reporting system (2015-2025).},
  author = {Song W and Chen H and Wang M and Liang Z},
  year = {2026},
  journal = {Frontiers in cellular and infection microbiology},
  doi = {10.3389/fcimb.2026.1831548},
  url = {https://doi.org/10.3389/fcimb.2026.1831548}
}

RIS

TY  - JOUR
TI  - Post-marketing safety surveillance of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine: a disproportionality analysis of the vaccine adverse event reporting system (2015-2025).
AU  - Song W
AU  - Chen H
AU  - Wang M
AU  - Liang Z
PY  - 2026
JO  - Frontiers in cellular and infection microbiology
DO  - 10.3389/fcimb.2026.1831548
UR  - https://doi.org/10.3389/fcimb.2026.1831548
ER  - 

APA

W, S., H, C., M, W., & Z, L. (2026). Post-marketing safety surveillance of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine: a disproportionality analysis of the vaccine adverse event reporting system (2015-2025).. Frontiers in cellular and infection microbiology. https://doi.org/10.3389/fcimb.2026.1831548

Source records